Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'PharmaVitae : Sepracor' returned 8 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Sepracor Inc.: PharmaVitae Model   Datamonitor, Jan 2009 and pipeline data Sepracor Inc.: PharmaVitae Model Sepracor Inc.: PharmaVitae Profile   Datamonitor, March 2009, Pages: 105 performance, 2001-13 Sepracor: PharmaVitae forecasts at a glance Strategic insight Stereoisomer purification drives unique business model Near-term growth potential squeezed by market pressures Xopenex Forest Laboratories Inc.: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 67 , will generate new growth for the company Executive Summary Key findings Prescription pharmaceutical sales and growth rate analysis, 2003– Operating costs and profit analysis COMPANY: PharmaVitae Shire plc: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 62 Prescription pharmaceutical sales and growth rate performance, 2003– Financial performance, 2003– Shire: PharmaVitae forecasts at a glance Strategic insight Shire’s ADHD franchise growth Sanofi-Aventis: PharmaVitae Profile   Datamonitor, Nov 2010, Pages: 135 Novo Nordisk A/S Oxford BioMedica Plc Pfizer Inc Regeneron Pharmaceuticals, Inc. Safety Insurance Group, Inc. Sanofi-Aventis Sepracor Inc. Sanofi-Aventis: PharmaVitae Profile H. Lundbeck A/S: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 58 this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter 2 Executive summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003–15 Financial Nycomed S.C.A. SICAR: PharmaVitae Profile   Datamonitor, July 2010, Pages: 75 pharmaceutical business model - Examine Nycomed's growth potential in the face of a blockbuster patent expiry Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Executive summary Solvay S.A.: PharmaVitae Profile   Datamonitor, March 2009, Pages: 134 ., Inc. Nektar Therapeutics Nycomed International Management GmbH Pfizer Inc Safety Insurance Group, Inc. Sepracor Inc. Servier Solvay Group Wyeth Solvay S.A.: PharmaVitae Profile Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network